6,488
Views
14
CrossRef citations to date
0
Altmetric
Coronavirus – Research Paper

Effectiveness of COVID-19 vaccine (Covaxin) against breakthrough SARS-CoV-2 infection in India

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & show all
Article: 2034456 | Received 16 Sep 2021, Accepted 24 Jan 2022, Published online: 23 Mar 2022

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Tin Kyaw, Grant Drummond, Alex Bobik & Karlheinz Peter. (2023) Myocarditis: causes, mechanisms, and evolving therapies. Expert Opinion on Therapeutic Targets 27:3, pages 225-238.
Read now
Taeyoung Park, Hyogyeong Hwang, Suhyeong Moon, Sang Gu Kang, Seunghyup Song, Young Hun Kim, Hanbi Kim, Eun-Ju Ko, Soon-Do Yoon, Sang-Moo Kang & Hye Suk Hwang. (2022) Vaccines against SARS-CoV-2 variants and future pandemics. Expert Review of Vaccines 21:10, pages 1363-1376.
Read now
Arvind Kumar Singh, Manoj Kumar Panigrahi, Somen Kumar Pradhan, Debkumar Pal, Sonu H. Subba, Binod Kumar Patro, Binod Kumar Behera, Baijayantimala Mishra, Bijayini Behera, Prasanta Raghab Mohapatra, Sourin Bhuniya, Shakti Kumar Bal, Saurav Sarkar, Jawahar S. K Pillai, Sachidananda Mohanty & Batmanabane Gitanjali. (2022) Clinico-Epidemiological Characteristics of Healthcare Workers with SARS-CoV-2 Infection during the First and Second Waves in a Teaching Hospital from Eastern India: A Comparative Analysis. Hospital Topics 0:0, pages 1-12.
Read now

Articles from other publishers (11)

Ranjeet Maurya, Uzma Shamim, Pallavi Mishra, Aparna Swaminathan, Aakarshan Raina, Bansidhar Tarai, Sandeep Budhiraja & Rajesh Pandey. (2023) Intertwined Dysregulation of Ribosomal Proteins and Immune Response Delineates SARS-CoV-2 Vaccination Breakthroughs. Microbiology Spectrum 11:3.
Crossref
Halie M. Rando, Ronan Lordan, Alexandra J. Lee, Amruta Naik, Nils Wellhausen, Elizabeth Sell, Likhitha Kolla, Anthony Gitter, Casey S. Greene, Vikas Bansal, John P. Barton, Simina M. Boca, Joel D. Boerckel, Christian Brueffer, James Brian Byrd, Stephen Capone, Shikta Das, Anna Ada Dattoli, John J. Dziak, Jeffrey M. Field, Soumita Ghosh, Anthony Gitter, Rishi Raj Goel, Casey S. Greene, Marouen Ben Guebila, Daniel S. Himmelstein, Fengling Hu, Nafisa M. Jadavji, Jeremy P. Kamil, Sergey Knyazev, Likhitha Kolla, Alexandra J. Lee, Ronan Lordan, Tiago Lubiana, Temitayo Lukan, Adam L. MacLean, David Mai, Serghei Mangul, David Manheim, Lucy D’Agostino McGowan, Jesse G. Meyer, Ariel I. Mundo, Amruta Naik, YoSon Park, Dimitri Perrin, Yanjun Qi, Diane N. Rafizadeh, Bharath Ramsundar, Halie M. Rando, Sandipan Ray, Michael P. Robson, Vincent Rubinetti, Elizabeth Sell, Lamonica Shinholster, Ashwin N. Skelly, Yuchen Sun, Yusha Sun, Gregory L. Szeto, Ryan Velazquez, Jinhui Wang & Nils Wellhausen. (2023) Application of Traditional Vaccine Development Strategies to SARS-CoV-2. mSystems 8:2.
Crossref
Naina Khullar, Jasvinder Singh Bhatti, Satwinder Singh, Bhawana Thukral, P Hemachandra Reddy & Gurjit Kaur Bhatti. (2023) Insight into the liver dysfunction in COVID-19 patients: Molecular mechanisms and possible therapeutic strategies. World Journal of Gastroenterology 29:14, pages 2064-2077.
Crossref
Sultan Ayoub Meo, Riham A. ElToukhy, Anusha Sultan Meo & David C. Klonoff. (2023) Comparison of Biological, Pharmacological Characteristics, Indications, Contraindications, Efficacy, and Adverse Effects of Inactivated Whole-Virus COVID-19 Vaccines Sinopharm, CoronaVac, and Covaxin: An Observational Study. Vaccines 11:4, pages 826.
Crossref
Atreyee Sarkar & ShanteeDevi Karri. (2023) Is COVID-19 over in India? A review based on current evidence. Journal of Indira Gandhi Institute Of Medical Sciences 9:1, pages 5.
Crossref
Haneen Imad Abufares, Leen Oyoun Alsoud, Mohammad A. Y. Alqudah, Mohd Shara, Nelson C. Soares, Karem H. Alzoubi, Waseem El-Huneidi, Yasser Bustanji, Sameh S. M. Soliman & Mohammad H. Semreen. (2022) COVID-19 Vaccines, Effectiveness, and Immune Responses. International Journal of Molecular Sciences 23:23, pages 15415.
Crossref
Xiuhong Yang, Hua Zhang, Wenjing Bao, Shunkun Fu & Huimin Jin. (2022) Immunogenicity Rates after SARS-CoV-2 Three-Dose Vaccination in Patients under Dialysis: A Systematic Review and Meta-Analysis. Vaccines 10:12, pages 2070.
Crossref
Zeting Liu, Huixuan Zhou, Ningxin Ding, Jihua Jia, Xinhua Su, Hong Ren, Xiao Hou, Wei Zhang & Chenzhe Liu. (2022) Modeling the effects of vaccination, nucleic acid testing, and face mask wearing interventions against COVID-19 in large sports events. Frontiers in Public Health 10.
Crossref
Aashish Contractor, Shashikala Shivaprakash, Anjali Tiwari, Maninder Singh Setia & Tarang Gianchandani. (2022) Effectiveness of Covid-19 vaccines (CovishieldTM and Covaxin ®) in healthcare workers in Mumbai, India: A retrospective cohort analysis. PLOS ONE 17:10, pages e0276759.
Crossref
Pragya D. Yadav, Sreelekshmy Mohandas, Anita Shete, Gajanan Sapkal, Gururaj Deshpande, Abhimanyu Kumar, Kundan Wakchaure, Hitesh Dighe, Rajlaxmi Jain, Brunda Ganneru, Jyoti Yemul, Pranita Gawande, Krishna Mohan Vadrevu & Priya Abraham. (2022) Protective efficacy of COVAXIN® against Delta and Omicron variants in hamster model. iScience 25:10, pages 105178.
Crossref
Wei Qin, Xiaqing Zhang, Yao Wang, Fan Pan, Kai Cheng, Fangfang Huang, Jian Song & Hong Su. (2022) The acceptance to heterologous booster vaccination of COVID-19 vaccine among HCWs and targeted population: A cross-sectional study in central China. Frontiers in Public Health 10.
Crossref